Indivior Pharmaceuticals, Inc. (DELISTED) (INDV:DL)
36.28
+0.91
(+2.57%)
USD |
NASDAQ |
Nov 02, 16:00
Indivior Pharmaceuticals Net Income (TTM) : 450.00M for Sept. 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 450.00M |
| June 30, 2026 | 355.00M |
| March 31, 2026 | 251.00M |
| December 31, 2025 | 209.00M |
| September 30, 2025 | 128.00M |
| June 30, 2025 | 108.00M |
| March 31, 2025 | -7.00M |
| December 31, 2024 | 7.00M |
| September 30, 2024 | 40.00M |
| June 30, 2024 | -117.00M |
| March 31, 2024 | 19.00M |
| December 31, 2023 | 2.00M |
| September 30, 2023 | -235.00M |
| June 30, 2023 | -59.00M |
| March 31, 2023 | -50.00M |
| December 31, 2022 | -53.00M |
| September 30, 2022 | 165.00M |
| June 30, 2022 | 151.00M |
| March 31, 2022 | 165.00M |
| December 31, 2021 | 204.00M |
| September 30, 2021 | 156.00M |
| June 30, 2021 | 139.00M |
| Date | Value |
|---|---|
| March 31, 2021 | 95.00M |
| December 31, 2020 | -148.00M |
| September 30, 2020 | -190.00M |
| June 30, 2020 | -152.00M |
| March 31, 2020 | -95.00M |
| December 31, 2019 | 134.00M |
| September 30, 2019 | 213.00M |
| June 30, 2019 | 254.00M |
| March 31, 2019 | 249.00M |
| December 31, 2018 | 276.00M |
| September 30, 2018 | 107.00M |
| June 30, 2018 | 68.00M |
| March 31, 2018 | 71.00M |
| December 31, 2017 | 58.00M |
| September 30, 2017 | 281.00M |
| June 30, 2017 | 82.00M |
| March 31, 2017 | 66.00M |
| December 31, 2016 | 36.00M |
| September 30, 2016 | -5.00M |
| June 30, 2016 | 192.00M |
| March 31, 2016 | 201.00M |
| December 31, 2015 | 228.00M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Supernus Pharmaceuticals, Inc. | -43.86M |
| Bristol Myers Squibb Co. | 9.242B |
| Eli Lilly & Co. | 27.58B |
| Ligand Pharmaceuticals, Inc. | 51.46M |
| Amneal Pharmaceuticals, Inc. | 209.49M |